{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T08:40:10Z","timestamp":1746520810681,"version":"3.40.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99499-3","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:11:11Z","timestamp":1746184271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic biomarker RIMS1 and its association with immune infiltration in glioblastoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Erxing","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qimin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqiang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangbin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"issue":"7","key":"99499_CR1","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.celrep.2020.01.073","volume":"30","author":"R Lucero","year":"2020","unstructured":"Lucero, R. et al. Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells. Cell. Rep. 30(7), 2065\u20132074e4 (2020).","journal-title":"Cell. Rep."},{"issue":"1","key":"99499_CR2","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1038\/s41467-023-39933-0","volume":"14","author":"Y Zheng","year":"2023","unstructured":"Zheng, Y. et al. Spatial cellular architecture predicts prognosis in glioblastoma. Nat. Commun. 14(1), 4122 (2023).","journal-title":"Nat. Commun."},{"issue":"4","key":"99499_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan, A. C. et al. Management of glioblastoma: state of the Art and future directions. CA Cancer J. Clin. 70(4), 299\u2013312 (2020).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"99499_CR4","doi-asserted-by":"publisher","first-page":"9219","DOI":"10.1038\/s41598-021-88615-8","volume":"11","author":"M Yeh","year":"2021","unstructured":"Yeh, M. et al. MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44. Sci. Rep. 11(1), 9219 (2021).","journal-title":"Sci. Rep."},{"key":"99499_CR5","doi-asserted-by":"publisher","first-page":"1274587","DOI":"10.3389\/fonc.2023.1274587","volume":"13","author":"K Szklener","year":"2023","unstructured":"Szklener, K. et al. Enhancing glioblastoma treatment through the integration of tumor-treating fields. Front. Oncol. 13, 1274587 (2023).","journal-title":"Front. Oncol."},{"issue":"1","key":"99499_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11060-021-03755-1","volume":"153","author":"A Dono","year":"2021","unstructured":"Dono, A. et al. PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma. J. Neurooncol. 153(1), 153\u2013160 (2021).","journal-title":"J. Neurooncol."},{"issue":"16","key":"99499_CR7","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1016\/j.cell.2023.06.020","volume":"186","author":"G Dolton","year":"2023","unstructured":"Dolton, G. et al. Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy. Cell 186(16), 3333\u20133349e27 (2023).","journal-title":"Cell"},{"key":"99499_CR8","doi-asserted-by":"crossref","unstructured":"Shin, M. H. et al. Recent advances in CAR-Based solid tumor immunotherapy. Cells 12, 12 (2023).","DOI":"10.3390\/cells12121606"},{"issue":"4","key":"99499_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s12094-023-03304-4","volume":"26","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Tumor metabolic crosstalk and immunotherapy. Clin. Transl Oncol. 26(4), 797\u2013807 (2024).","journal-title":"Clin. Transl Oncol."},{"key":"99499_CR10","doi-asserted-by":"publisher","first-page":"1212476","DOI":"10.3389\/fimmu.2023.1212476","volume":"14","author":"R Rui","year":"2023","unstructured":"Rui, R., Zhou, L. & He, S. Cancer immunotherapies: advances and bottlenecks. Front. Immunol. 14, 1212476 (2023).","journal-title":"Front. Immunol."},{"key":"99499_CR11","doi-asserted-by":"publisher","first-page":"106074","DOI":"10.1016\/j.nbd.2023.106074","volume":"180","author":"S Sran","year":"2023","unstructured":"Sran, S. & Bedrosian, T. A. RAS pathway: the new frontier of brain mosaicism in epilepsy. Neurobiol. Dis. 180, 106074 (2023).","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"99499_CR12","doi-asserted-by":"publisher","first-page":"19893","DOI":"10.1038\/s41598-024-70854-0","volume":"14","author":"P Ray","year":"2024","unstructured":"Ray, P., Sarker, D. K. & Uddin, S. J. Bioinformatics and computational studies of chabamide F and chabamide G for breast cancer and their probable mechanisms of action. Sci. Rep. 14(1), 19893 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"99499_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41413-024-00350-8","volume":"12","author":"K Li","year":"2024","unstructured":"Li, K. et al. The HOXC10\/NOD1\/ERK axis drives osteolytic bone metastasis of pan-KRAS-mutant lung cancer. Bone Res. 12(1), 47 (2024).","journal-title":"Bone Res."},{"issue":"9","key":"99499_CR14","doi-asserted-by":"publisher","first-page":"103677","DOI":"10.1016\/j.esmoop.2024.103677","volume":"9","author":"A Alig","year":"2024","unstructured":"Alig, A. et al. Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI. ESMO Open. 9(9), 103677 (2024).","journal-title":"ESMO Open."},{"issue":"4","key":"99499_CR15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1158\/2159-8290.CD-21-1331","volume":"12","author":"MH Hofmann","year":"2022","unstructured":"Hofmann, M. H. et al. Expanding the reach of precision oncology by drugging all KRAS mutants. Cancer Discov. 12(4), 924\u2013937 (2022).","journal-title":"Cancer Discov"},{"key":"99499_CR16","doi-asserted-by":"crossref","unstructured":"Fan, F. et al. Dynamin deficiency causes insulin secretion failure and hyperglycemia. Proc. Natl. Acad. Sci. U S A 118, 32 (2021).","DOI":"10.1073\/pnas.2021764118"},{"issue":"9","key":"99499_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/iovs.63.9.14","volume":"63","author":"MP Martin-Gutierrez","year":"2022","unstructured":"Martin-Gutierrez, M. P. et al. Dominant cone rod dystrophy, previously assigned to a missense variant in RIMS1, is fully explained by Co-Inheritance of a dominant allele of PROM1. Invest. Ophthalmol. Vis. Sci. 63(9), 14 (2022).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"99499_CR18","doi-asserted-by":"publisher","first-page":"100192","DOI":"10.1016\/j.mcpro.2021.100192","volume":"21","author":"B Andrews","year":"2022","unstructured":"Andrews, B. et al. Multidimensional dynamics of the proteome in the neurodegenerative and aging mammalian brain. Mol. Cell. Proteom. 21(2), 100192 (2022).","journal-title":"Mol. Cell. Proteom."},{"issue":"6","key":"99499_CR19","first-page":"3882","volume":"15","author":"W Zhen","year":"2023","unstructured":"Zhen, W. et al. Exploration and validation of m7G-related genes as signatures in the immune microenvironment and prognostic indicators in low-grade glioma. Am. J. Transl. Res. 15(6), 3882\u20133899 (2023).","journal-title":"Am. J. Transl. Res."},{"issue":"9\u201310","key":"99499_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41417-018-0015-4","volume":"25","author":"J Yang","year":"2018","unstructured":"Yang, J. et al. Gene expression profiles reveal key genes for early diagnosis and treatment of adamantinomatous craniopharyngioma. Cancer Gene Ther. 25(9\u201310), 227\u2013239 (2018).","journal-title":"Cancer Gene Ther."},{"key":"99499_CR21","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/j.wneu.2023.05.006","volume":"176","author":"S Zhang","year":"2023","unstructured":"Zhang, S., Luo, Y., Sun, W., Tan, W. & Zeng, H. Prognostic values of core genes in pilocytic astrocytom. World Neurosurg. 176, e101\u2013e108 (2023).","journal-title":"World Neurosurg."},{"key":"99499_CR22","doi-asserted-by":"crossref","unstructured":"Zhang, Q. et al. Bioinformatics approach based on the Cancer-Immune cycle identifies potential immunotherapeutic targets in diffuse gliomas  (2022).","DOI":"10.21203\/rs.3.rs-2304486\/v1"},{"key":"99499_CR23","doi-asserted-by":"publisher","first-page":"111776","DOI":"10.1016\/j.biopha.2021.111776","volume":"140","author":"A Tajbakhsh","year":"2021","unstructured":"Tajbakhsh, A. et al. The complex roles of efferocytosis in cancer development, metastasis, and treatment. Biomed. Pharmacother. 140, 111776 (2021).","journal-title":"Biomed. Pharmacother"},{"issue":"1","key":"99499_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12920-023-01688-4","volume":"16","author":"S Zhao","year":"2023","unstructured":"Zhao, S. et al. Interaction, immune infiltration characteristics and prognostic modeling of efferocytosis-related subtypes in glioblastoma. BMC Med. Genomics. 16(1), 248 (2023).","journal-title":"BMC Med. Genomics"},{"issue":"10","key":"99499_CR25","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41571-022-00671-9","volume":"19","author":"SR Punekar","year":"2022","unstructured":"Punekar, S. R. et al. The current state of the Art and future trends in RAS-targeted cancer therapies. Nat. Rev. Clin. Oncol. 19(10), 637\u2013655 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"99499_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3389\/fonc.2019.00965","volume":"9","author":"RC Gimple","year":"2019","unstructured":"Gimple, R. C. & Wang, X. Striking at the core of the oncogenic circuitry. Front. Oncol. 9, 965 (2019).","journal-title":"Front. Oncol."},{"key":"99499_CR27","doi-asserted-by":"crossref","unstructured":"Hymowitz, S. G. & Malek, S. Targeting the MAPK pathway in RAS mutant cancers. Cold Spring Harb Perspect. Med., 8, 11 (2018).","DOI":"10.1101\/cshperspect.a031492"},{"key":"99499_CR28","doi-asserted-by":"publisher","first-page":"107293","DOI":"10.1016\/j.lungcan.2023.107293","volume":"184","author":"T Lim","year":"2023","unstructured":"Lim, T. et al. KRAS G12C in advanced NSCLC: prevalence, co-mutations, and testing. Lung Cancer. 184, 107293 (2023).","journal-title":"Lung Cancer"},{"key":"99499_CR29","doi-asserted-by":"publisher","first-page":"114690","DOI":"10.1016\/j.expneurol.2024.114690","volume":"374","author":"K Snyder","year":"2024","unstructured":"Snyder, K. et al. Gene knockout of RNA binding motif 5 in the brain alters RIMS2 protein homeostasis in the cerebellum and Hippocampus and exacerbates behavioral deficits after a TBI in mice. Exp. Neurol. 374, 114690 (2024).","journal-title":"Exp. Neurol."},{"issue":"5","key":"99499_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/labinvest.2017.19","volume":"97","author":"A Gieryng","year":"2017","unstructured":"Gieryng, A. et al. Immune microenvironment of gliomas. Lab. Invest. 97(5), 498\u2013518 (2017).","journal-title":"Lab. Invest."},{"key":"99499_CR31","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fimmu.2013.00116","volume":"4","author":"DA Wainwright","year":"2013","unstructured":"Wainwright, D. A. et al. Targeting Tregs in malignant brain cancer: overcoming IDO. Front. Immunol. 4, 116 (2013).","journal-title":"Front. Immunol."},{"issue":"9","key":"99499_CR32","doi-asserted-by":"publisher","first-page":"e70013","DOI":"10.1111\/cns.70013","volume":"30","author":"AW Andrew","year":"2024","unstructured":"Andrew, A. W. et al. Immunotherapeutic advances in glioma management: the rise of vaccine-based approaches. CNS Neurosci. Ther. 30(9), e70013 (2024).","journal-title":"CNS Neurosci. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99499-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99499-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99499-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T08:27:45Z","timestamp":1746520065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99499-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99499"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99499-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the The First Affiliated Hospital, Jiangxi Medical College, Nanchang University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"15240"}}